Causality Assessment in Premarketing Drug Clinical Trials: Regulatory Evolution in the USA and Ongoing Concerns
Crossref DOI link: https://doi.org/10.1007/s40264-016-0442-9
Published Online: 2016-10-04
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goldman, Stephen A.
License valid from 2016-10-01